Chimerix (CHMX) PT Lifted to $50 at Brean Capital

May 11, 2015 12:37 PM

Brean Capital analyst Jonathan Aschoff reiterated a Buy rating and boosted his price target on Chimerix (NASDAQ: CMRX) to $50.00 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found